Affiliation:
1. Department of Geriatrics, Hospital Universitari Mútua-Terrassa, University of Barcelona, 08007 Barcelona, Spain
2. Department of Endocrinology, Hospital Universitari Mútua-Terrassa, University of Barcelona, 08007 Barcelona, Spain
3. Department of Internal Medicine, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Universitari de Bellvitge, University of Barcelona, 08007 Barcelona, Spain
Abstract
Objectives: With the increasing prevalence of diabetes and frailty among older adults, there is an urgent need for precision medicine that incorporates comprehensive geriatric assessments, including frailty detection. This scoping review aims to map and synthesize the available evidence on validated tools for detecting pre-frailty and frailty in community-dwelling elderly individuals with diabetes and outpatient diabetes patients. Specifically, it addresses: (1) What validated tools are available for detecting pre-frailty and frailty in this population? (2) How are these tools associated with outcomes such as glycemic control, hypoglycemia, and metabolic phenotypes? (3) What gaps exist in the literature regarding these tools? Methods: The review followed PRISMA-ScR guidelines, conducting a systematic search across PubMed, Cochrane Library, and Web of Science. The inclusion criteria focused on studies involving individuals aged 70 years and older with diabetes, emphasizing tools with predictive capacity for disability and mortality. Results: Eight instruments met the inclusion criteria, including the Frailty Index, Physical Frailty Phenotype, and Clinical Frailty Scale. These tools varied in domains such as physical, psychological, and social aspects of frailty and their association with glycemic control, hypoglycemia, and metabolic phenotypes. The review identified significant gaps in predicting diabetes-related complications and their clinical application. Conclusions: Routine management of older adults with diabetes should incorporate frailty detection, as it is crucial for their overall health. Although widely used, the reviewed tools require refinement to address the unique characteristics of this population. Developing tailored instruments will enhance precision medicine, leading to more effective, individualized interventions for elderly individuals with diabetes.
Reference126 articles.
1. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045;Sun;Diabetes Res. Clin. Pract.,2022
2. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study;Soriguer;Diabetologia.,2012
3. Paciente anciano con diabetes mellitus y fragilidad. ¿Asociación siempre presente? [Elderly patients with diabetes mellitus and frailty. Association always present?];Formiga;Rev. Esp. Geriatr. Gerontol.,2014
4. Rodríguez-Mañas, L., Sinclair, A.J., and Castro-Rodríguez, M. (2015). El anciano con Diabetes Mellitus. En: Tratado de Medicina Geriátrica, Elsevier. [1st ed.].
5. Chhetri, J.K., Zheng, Z., Xu, X., Ma, C., and Chan, P. (2017). The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: Results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr., 17.